| Not Yet Recruiting | SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates Advanced or Metastatic Solid Tumour, Antibody-Drug Conjugate, Alopecia | Phase 2 | 2026-09-01 |
| Not Yet Recruiting | Flash Radiotherapy for Skin Cancer Cutaneous Squamous Cell Carcinoma (CSCC), Basal Cell Carcinoma (BCC) | Phase 2 | 2026-03-23 |
| Not Yet Recruiting | Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritonea Peritoneal (Metastatic) Cancer, Colorectal Cancer, Colorectal (Colon or Rectal) Cancer | — | 2026-03-01 |
| Not Yet Recruiting | Prophylactic Intervention for Dysgeusia in Head and Neck Cancer Patients Following Radio(Chemo)Therapy Head and Neck Cancer (H&N) | N/A | 2026-02-16 |
| Recruiting | Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of Life Hypotestosteronism, Palliative Care | EARLY_Phase 1 | 2026-02-11 |
| Recruiting | HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequ HER2-positive Metastatic Breast Cancer, HER2-positive Advanced Breast Cancer | Phase 2 | 2026-02-01 |
| Recruiting | LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated Wi Prostate Cancer (Adenocarcinoma) | — | 2026-02-01 |
| Recruiting | Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management. Ventral Hernias, Cytoreductive Surgery | — | 2026-01-20 |
| Recruiting | Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study OligoProgressive Metastatic Disease | N/A | 2025-10-30 |
| Recruiting | Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study. Glioblastoma | N/A | 2025-08-01 |
| Recruiting | Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt) Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer | Phase 2 | 2025-05-12 |
| Recruiting | The Role of the Imaging FAPI PET/CT in Exploring the Microenvironment of Colorectal Cancer Liver Metastases Liver Metastases From Colorectal Cancer | N/A | 2025-05-09 |
| Not Yet Recruiting | Evaluation of the RESTART Survival Programme Invasive Breast Cancer | — | 2025-03-01 |
| Recruiting | Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatect Prostate Cancer | N/A | 2024-12-10 |
| Recruiting | The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing Multiparametric MRI, Lesion PI-RADS 3 | N/A | 2024-10-17 |
| Withdrawn | A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multipl Multiple Myeloma, Refractory, Multiple Myeloma in Relapse, Multiple Myeloma Progression | Phase 1 | 2024-10-01 |
| Not Yet Recruiting | Assessment of DW-MRI Measures : Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy V Rectum Cancer, Pelvic Cancer | N/A | 2024-06-13 |
| Recruiting | ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study Breast Cancer | N/A | 2024-02-12 |
| Recruiting | Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients Wit Locally Advanced Rectal Cancer, Older People | N/A | 2024-02-07 |
| Active Not Recruiting | A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients Unresectable Locally Advanced Colorectal Cancer, Metastatic Colorectal Cancer, Candidate for Third-line or Subsequent Lines of Therapy | N/A | 2023-10-12 |
| Completed | PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ) Prostate Cancer, Radiotherapy Side Effect, Bowel Dysfunction | N/A | 2023-10-06 |
| Unknown | To Explore the Benefits of the MonaLisa Touch® System in Gynaecological Cancer Patients Treated by (Chemo)-RT Gynecologic Cancer | N/A | 2023-09-01 |
| Recruiting | Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhi Non Small Cell Lung Cancer | N/A | 2023-06-13 |
| Recruiting | Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis Cancer, Peritoneal Carcinomatosis | N/A | 2023-05-30 |
| Unknown | Immunological Variables Associated to ICI Toxicity in Cancer Patients Breast Cancer, Melanoma, Non Small Cell Lung Cancer | Phase 2 | 2022-09-01 |
| Recruiting | Multidisciplinary Approach to Fatigue Breast Cancer, Germ Cell Tumor | N/A | 2022-08-19 |
| Completed | Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal Met Carcinomatosis, Peritoneal | N/A | 2022-06-16 |
| Recruiting | PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-n TNBC - Triple-Negative Breast Cancer | Phase 2 | 2022-05-30 |
| Completed | Inferior Epigastric Lymph Node in Colorectal Carcinosis Colorectal Carcinomatosis | N/A | 2022-02-03 |
| Terminated | De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer | Phase 2 | 2022-01-17 |
| Terminated | COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 Cancer | Phase 4 | 2021-12-01 |
| Withdrawn | Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metasta Breast Cancer, Brain Metastases | Phase 2 | 2021-11-24 |
| Unknown | Advanced Cancer Patients' and Their Primary Caregivers' Willingness to Communicate About Advance Care Planning Advanced Cancer | — | 2021-10-04 |
| Unknown | ProCaLung: Project on Cancer of the Lung Locally Advanced Lung Carcinoma | — | 2021-10-01 |
| Active Not Recruiting | Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic Features Head and Neck Cancer, Dysphagia | N/A | 2021-04-01 |
| Active Not Recruiting | Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Can Rectal Cancer Stage II, Rectal Cancer Stage III | Phase 2 | 2021-03-25 |
| Unknown | Micro-wave Ablation Under Organ-based Tracking in Patients With Prostate Cancer - FOSTINE Focal Treatment for Prostate Cancer | N/A | 2021-03-01 |
| Active Not Recruiting | Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer | Phase 2 | 2021-01-14 |
| Unknown | Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold. Radiodermatitis, Radiation Toxicity, Radiotherapy Side Effect | Phase 1 / Phase 2 | 2021-01-01 |
| Unknown | A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural Setting Adults, Hematological Malignancy, Oral Antineoplastic Agents | — | 2020-12-01 |
| Active Not Recruiting | Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck C Head and Neck Squamous Cell Carcinoma | Phase 2 | 2020-11-17 |
| Recruiting | A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours CNS Metastases | N/A | 2020-07-01 |
| Completed | Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients Multiple Myeloma | Phase 2 | 2020-02-25 |
| Recruiting | Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiot Oropharyngeal Cancer | Phase 3 | 2019-12-16 |
| Active Not Recruiting | Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, + Luminal B | Phase 2 | 2019-11-06 |
| Active Not Recruiting | Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Ino Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2018-12-28 |
| Completed | Multiorgan Metabolic Imaging Response Assessment of Abemaciclib Esophageal Adenocarcinoma, Esophagus SCC, Cholangiocarcinoma | Phase 2 | 2018-12-19 |
| Completed | Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial) Non-metastatic Muscle Invasive Bladder Cancer | Phase 2 | 2018-06-01 |
| Withdrawn | Kadcyla In pAtients With bRAin Metastasis Metastatic HER2-positive Breast Cancer With Brain Metastasis | Phase 2 | 2018-02-23 |
| Withdrawn | Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Squamous Cell Carcinoma of the Esophagus | Phase 1 / Phase 2 | 2017-07-20 |
| Completed | Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Posit Breast Cancer Female | Phase 2 | 2017-07-05 |
| Completed | Safety of Pregnancy in BRCA Mutated Breast Cancer Patients Breast Cancer | — | 2017-01-16 |
| Withdrawn | Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patie Prostate Cancers | Phase 2 | 2016-10-01 |
| Unknown | Randomized Controlled Trial Assessing the Efficacy of a Communication Skills Training Program Physician Patient Relationship | N/A | 2016-08-01 |
| Completed | Double-blind Study to Assess effectIveness of Pectoral Nerves Block After Breast Surgery on Piritramide Consum Locoregional Analgesia in Breast Surgery | Phase 3 | 2016-05-01 |
| Withdrawn | Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer Breast Cancer | Phase 2 | 2015-06-01 |
| Withdrawn | Randomized Phase III of PRRT Versus Interferon Gastro-intestinal Neuroendocrine Tumors | Phase 3 | 2014-12-01 |
| Withdrawn | TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosph Breast Cancer | Phase 2 | 2014-10-01 |
| Unknown | Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disea Refractory Chronic Graft Versus Host Disease (cGVHD) | Phase 2 | 2014-09-01 |
| Completed | Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women Breast Cancer | Phase 2 | 2014-01-12 |
| Completed | Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy Breast Cancer | Phase 2 | 2014-01-01 |
| Unknown | Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Thera Breast Cancer | Phase 2 | 2013-12-01 |
| Completed | The Jules Bordet Institute Molecular Profiling Program Feasibility Trial Colorectal Cancer Metastatic, Metastatic Melanoma, Metastatic Non-Small Cell Lung Carcinoma | N/A | 2013-12-01 |
| Unknown | NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG Head and Neck Cancer | Phase 2 | 2013-12-01 |
| Completed | Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cance Metastatic Colorectal Cancers, Metastatic Gastric Cancers, Metastatic Oesophageal Cancers | Phase 1 | 2013-09-01 |
| Withdrawn | Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC Brain Metastasis, Breast Cancer, Non Small Cell Lung Cancer | Phase 2 | 2013-09-01 |
| Completed | Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C) Advanced Chemorefractory Colorectal Adenocarcinoma | Phase 2 | 2013-08-01 |
| Unknown | Evaluation of Two Techniques for the SLN Detection in BC Patients Breast Cancer | Phase 2 | 2013-07-01 |
| Terminated | A Study to Evaluate Denosumab in Young Patients With Primary Breast Cancer Breast Neoplasms | Phase 2 | 2013-07-01 |
| Completed | 177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs Gastroenteropancreatic Neuroendocrine Tumors | Phase 3 | 2013-05-01 |
| Completed | BIG Molecular Screening Feasibility Study Metastatic Breast Cancer | N/A | 2013-05-01 |
| Completed | Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer Colorectal Cancer, Peritoneal Carcinomatosis | Phase 2 | 2013-03-01 |
| Completed | Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients Ovarian Cancer, Peritoneal Carcinomatosis | Phase 1 / Phase 2 | 2013-03-01 |
| Completed | ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue. Breast Cancer. | Phase 1 / Phase 2 | 2013-01-01 |
| Completed | Indocyanine Green (ICG) in the ex Vivo Detection of Sentinel Lymph Node (SLN)in Colon Cancer Colon Cancer, Colon Surgery | — | 2013-01-01 |
| Terminated | Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Hepatocellular Carcinoma, Liver Cirrhosis | Phase 2 | 2012-09-01 |
| Unknown | Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia Breast Cancer | Phase 2 | 2012-07-01 |
| Completed | Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer Colorectal Cancer | N/A | 2012-06-01 |
| Completed | HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1 HER-2 Positive Breast Cancer | Phase 2 | 2012-05-01 |
| Unknown | Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion Acute Myelogenous Leukemia, Myeloid Leukemia in Remission, Effects of Immunotherapy | Phase 1 / Phase 2 | 2011-12-01 |
| Completed | Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer Breast Cancer | Phase 2 | 2011-11-01 |
| Completed | Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients Breast Neoplasms, Secondary, HER2 Positive Carcinoma of Breast | Phase 1 | 2011-08-01 |
| Terminated | Early Cardiac Toxicity of Adjuvant CT in Elderly BC. Breast Cancer | Phase 2 | 2011-03-01 |
| Completed | Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer Colorectal Cancer | Phase 2 | 2011-02-01 |
| Completed | Effects of Oxygen After Abdominal Oncological Surgery Abdominal Cancer | N/A | 2011-01-01 |
| Completed | Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients Breast Cancer | Phase 2 | 2010-07-01 |
| Completed | Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Lin Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | Phase 1 / Phase 2 | 2010-05-01 |
| Completed | Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast C Invasive Breast Cancer | — | 2010-02-01 |
| Completed | Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer Colon Cancer | N/A | 2009-11-01 |
| Completed | A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian C Ovarian Carcinoma, Relapse | Phase 2 | 2008-10-01 |
| Completed | Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer Metastatic Breast Cancer, Brain Metastases, HER2 Positive | Phase 1 | 2008-01-01 |
| Unknown | Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer Breast Cancer, Metastatic Cancer | N/A | 2006-09-01 |
| Completed | PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome. Colorectal Cancer Metastatic, Early Response Evaluation, Fdg-PET | — | 2006-06-01 |
| Completed | Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer Head and Neck Neoplasms | Phase 2 | 2005-04-01 |
| Completed | FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole Breast Cancer | Phase 2 | 2004-11-01 |
| Completed | PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2 Carcinoma Breast Stage IV | Phase 1 | 2003-10-01 |
| Completed | Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study Elderly Patients, Breast Cancer | Phase 2 | 2003-01-01 |
| Terminated | Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin Breast Cancer | Phase 2 | 2003-01-01 |
| Completed | Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Colorectal Neoplasm, Secondary Malignant Neoplasm of Liver | Phase 3 | — |